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1. Introduction 
It is well known that in both sexes thyroid hormones influence sexual development and 
reproductive function; clinical and experimental evidences suggest that the hypothalamic-
pituitary-thyroid axis and the hypothalamic-pituitary-ovary axis are physiologically related 
and act together as unified system in a number of pathological conditions (Doufas & 
Mastorakos, 2000).  
In women, both hyper- and hypo-thyroidism may result in menstrual disturbances. In 
hyperthyroidism the most common manifestations are simple oligomenorrhea and 
anovulatory cycles. Hypothyroidism results in changes in cycle length, amount of bleeding, 
and usually is associated with abnormal menstrual cycles characterized mainly by 
polymenorrhea and anovulatory cycles (Krassas et al., 1999). Also subclinical 
hypothyroxinemia can be associated with short luteal phase and insufficient progesterone 
secretion (Bohnet et al., 1981); similar pictures are present in a variety of situations 
characterized by low T3 levels (malnutrition, chronic illness, exercise), known as “non-
thyroidal illness” (De Groot, 2006). 
Interference between thyroid gland function and the ovary are described in three main 
areas: the secretion of GnRH, the peripheral metabolism of steroids and prolactin secretion. 
Previous studies demonstrated a direct ovarian effect: TSH possesses a luteotropic activity 
(Wurfel, 1992) and the expression of thyroid hormone receptors has been documented in all 
ovarian cell types: surface epithelial cells, oocytes, granulosa and theca cells, stromal cells 
(Dittrich et al., 2011). Many studies were also performed in males, both in animals and 
humans and extensively reviewed (Krassas et al., 2010). 
Despite the clinical relevance of the association between thyroid and reproductive health, its 
physiopathological mechanisms are still poorly understood and no definitive trials on 
thyroid hormone replacement allow unequivocal conclusions. Among the new mechanisms 
proposed, a link could be related to oxidative stress (OS). 
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Oxidative stress is defined as the unbalancing between production of free radicals, 
molecules characterized by high reactivity due to one or more unpaired electrons in the 
external orbital, and antioxidant defenses in the biological systems. Nowadays, it is 
considered an important pathogenetic mechanism in different diseases (Halliwell & 
Gutteridge, 1979). Among free radicals the most important and studied are reactive oxygen 
species (ROS), of which most in vivo production occurs mainly during oxidative processes of 
energetic substrates in the mitochondrial respiratory chain (Littarru, 1994; Kang & 
Hamasaki, 2003). However, other important kinds of free radicals exist, besides ROS, among 
which nitrogen reactive species are the most studied (Lancaster, 1992). 
An augmented ROS production can be the consequence of an augmented electronic flow in 
the respiratory chain, when it is activated by an increased energetic demand or contribution 
of substrates (Turrens & Boveris, 1980), as occurs in obesity. An uncontrolled production of 
free radicals is linked to many pathological events, such as rheumatoid arthritis and 
myocardial infarction (Littarru, 1994), and in general ROS damage occurs in inflamed 
tissues, characterized by cellular lysis and intracellular content release. Moreover in diabetes 
mellitus, oxidation accompanies glycation in vivo, while antioxidant capacity is decreased, 
finally resulting in an increased susceptibility to oxidative stress (Wolff et al., 1991). 
It is possible to characterize different cellular defensive mechanisms against the free radical 
damage (Littarru, 1994). The first mechanism is the prevention of production or the rapid 
inactivation of free radicals, thanks to the action of enzymes, like catalase, peroxidase 
glutathion complex and superoxydedismutase (SOD), or of transition-metal binding 
proteins, like transferrin, ferritin and ceruloplasmin. The second mechanism interrupts 
propagation of the lipid peroxidation chain by a reaction with the intermediate radicals and 
the consequent neutralization. This mechanism is acted by molecules called "scavengers", 
which can be water-soluble, such as albumin, bilirubin, ascorbic acid, urates and thiols, or 
liposoluble, such as vitamin E and coenzyme Q10, the only liposoluble antioxidant 
synthesized in living organisms. The mobility of scavengers, particularly the liposoluble 
ones and above all at membrane level, allows to intercept radicals and transform them into 
more stable molecules and therefore to stop radical chain. The third defensive mechanism 
uses processes which remove molecules damaged by oxidative attack, allowing the 
reconstitution of normal structures (e.g. specific phospholypases remove the peroxidized 
fatty acids, making possible the re-acylation of damaged molecule by an acyl-CoA and the 
respective enzyme) (Littarru, 1994). Different studies suggest that OS can be present in 
hypothyroidism and could be a factor involved in infertility associated to thyroid 
insufficiency. 
2. Thyroid hormones and oxidative stress 
Previous studies have shown that both hyperthyroidism and hypothyroidism are associated 
with enhanced oxidative stress involving enzymatic and non-enzymatic antioxidants (Resch 
et al., 2002). Besides, some complications of hyperthyroidism are due just to the oxidative 
stress in target tissues (Asayama & Kato, 1990). Thyroid hormones per se can act as oxidants 
and produce DNA-damage (contrasted by catalase), probably through the phenolic group, 
similar to that of steroidal estrogens (Dobrzynska et al., 2004). Many other mechanisms, 
reviewed by Venditti & Di Meo (2006), can be involved: enhanced NOS gene expression 
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with NO overproduction; activation of hepatic nuclear factor-kB and following increase of 
cytokines stimulating ROS generation; uncoupling mechanisms involving UCP-2 and UCP-
3, regulated by thyroid hormones; increased turnover of mitochondrial proteins; mitoptosis, 
regulated by peroxisome proliferator-activated receptor gamma coactivator-1, which is 
upregulated by T3 administration. Thyroid hormones influence lipid composition of rat 
tissues (Hoch, 1988) and therefore the susceptibility to oxidative stress.  
However, there is a specificity in tissue response, and discrepant effects of T3 and T4 are 
possible. In rat liver, T3-induced hyperthyroidism was found to be associated with altered 
lipid-peroxidation indices, including elevated levels of TBARS and hydroperoxydes 
(Fernandez et al., 1985; Venditti et al., 1997; Huth et al., 1998; Venditti et al., 1999). On the 
contrary, no change in TBARS was found in homogenized livers from rats made 
hyperthyroid by administration of T4 over a 4-week period (Asayama et al., 1987). As 
regards testis, no significant change (TBARS or hydroperoxydes) was observed in lipid 
peroxidation of hyperthyroid adult rats, but hyperthyroidism promoted protein oxidation 
rate as indicated by an enhanced content of protein-bound carbonyls (Choudhury et al., 
2003). In conclusion, we should emphasize the fact of a tissue-linked variability in the effects 
of hyperthyroidism on the activity of antioxidant enzymes (Mn-SOD or Cu,Zn-SOD, 
catalase, glutathion-peroxidase) with differential effects of the two thyroid hormones 
(Venditti & Di Meo, 2006).  
At a systemic level, also in humans, hyperthyroidism has been associated with reduced 
circulating levels of alpha-tocopherol (Ademoglu et al., 1998; Bianchi et al., 1990) and 
Coenzyme Q10 (Bianchi et al., 1990; Mancini et al., 1991). Coenzyme Q10 showed a trend to 
increase in hypothyroidism (Mancini et al., 1991); it appeared to be a sensitive index of 
tissue effect of thyroid hormones, in situations in which drug interference, such as 
amiodarone (Mancini et al., 1989) or systemic illness inducing a low-T3 conditions (Mancini 
et al., 2005) complicate the interpretation of thyroid hormone levels. 
However, data on hypothyroidism in humans are conflicting. Baskol et al showed in a 
group of 33 patients with primary hypothyroidism elevated malondialdehyde (MDA) and 
nitric oxide (NO) levels and low paraoxonase (PON1) activity, while superoxide dismutase 
(SOD) was not different from controls. Interestingly, thyroid treatment decreased MDA and 
increased PON1, without reaching levels observed in controls (Baskol et al., 2007). They 
concluded that a prooxidant environment in hypothyroidism could play a role in the 
pathogenesis of atherosclerosis in such patients. Elevated MDA levels were also shown in 
subclinical hypothyroidism (Torun et al., 2009); the increased in OS was attributed to lack of 
antioxidants but also to altered lipid metabolism, since MDA showed a correlation with 
LDL-cholesterol, total cholesterol and triglycerides.  Total antioxidant status (TAS) was 
similar in overt hypothyroidism, subclinical hypothyroidism and controls. 
Different studies confirmed the NO elevation (Coria et al., 2009; Erdamar et al., 2008).  Data 
on other parameters are more conflicting. As PON-1 is concerned, a decreased activity was 
observed both in hypo- and hyperthyroidism (Azizi et al., 2003), while not significant 
differences with controls were shown in other studies (Coria et al., 2009). 
Another study (Santi et al., 2010) showed increased levels of thiobarbituric acid reactive 
substances (TBARS), but also of antioxidants, such as SOD, catalase (CAT) and Vitamin E. 
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All these parameters correlated with T3; moreover the correlation between T3 and CAT 
remained significant also when corrected with total cholesterol. While TBARS elevation was 
also shown also in some studies (Nanda et al., 2007; Erdamar et al., 2008), other studies did 
not confirm the datum in overt hypothyroidism (Coria et al., 2009) and in subclinical 
hypothyroidism (Kebapcilar et al., 2007).  
We showed low Total Antioxidant Capacity (TAC) levels in hypothyroid patients (Mancini 
et al., 2010a) and increased CoQ10 levels also in secondary hypothyroidism (mainly due to 
its metabolic role in mitochondrial respiratory chain and therefore underutilized in 
hypothyroid tissue). In the last case, hypothyroidism has a predominant effect on other 
conditions influencing CoQ10 in opposite direction, such as acromegaly and hypoadrenalism 
(Mancini et al., 2010a; Mancini et al., 2010b). 
Finally, new perspectives concern DUOX (Dual OXidase) genes expression, which is crucial 
for H2O2 generation essential for thyroid peroxidase (TPO)-catalyzed thyroid hormone 
synthesis (Ohye & Sugawara, 2010). Two oxidases of such family are present in thyroid 
(DUOX1 and DUOX2) and work together maturation factors (DUOXA1 and DUOXA2), 
which allow DUOX proteins to translocate to the follicular cell membrane and exert their 
enzymatic activity (OHYE). Cases of hypothyroidism due to mutation of DUOX or DUOXA 
genes have been presented in literature (Varela et al., 2006; Ohye et al., 2008). While defects 
of this system interfere with thyroid hormone synthesis, another new intracellular ROS 
generating system has been demonstrated in the human thyroid gland: NADPH oxidase 4 
(NOX4) (Weyemi et al., 2010); defects in such a system could be associated with thyroid 
cancer (via activation by H-Ras oncongene) and Hashimoto’s thyroiditis (in such a situation 
increased extracellular production cause an increased ICAM-1 expression and cytokine 
release) (Sharma et al., 2008). 
3. Hypothyroidism and male infertility 
Hypothyroidism can cause interference with male fertility, both via endocrine mechanisms 
and direct effect on spermatogenesis, as recently reviewed (Krassas et al., 2010). The best 
definite alteration is the decrease in SHBG and total testosterone (T) concentrations, while 
free T are reduced in approximately 60% of hypothyroid male; thyroxine therapy induces an 
increase in free T (Donnelly & White, 2000). While in females PRL elevation in 
hypothyroidism is a crucial phenomenon inducing hypogonadism, in males PRL levels are 
not frequently augmented. Similarly, gonadotropin levels are often in the normal range, but 
a blunted gonadotropin (Gn) response to GnRH  support the hypothesis of a reduced 
pituitary responsiveness to hypothalamic stimulation (Velazquez & Bellabarba Arata, 1997). 
The exaggerated T response to hCG also underlines the role of hypothalamic-pituitary unit 
rather than a primary testicular effect. A decrease has also been shown in DHEA, DHEAS, 
andostendiol and pregnenolone sulfate (Tagawa et al., 2001). The endocrine dysfunction 
partially explain the sexual symptoms complained in such patients, such as decreased libido 
or erectile dysfunction (Carani et al., 2005; Krassas et al., 2008). 
The studies on hypothyroidism and spermatogenesis are not conclusive, since reports 
concerning small groups of patients are reported in literature (Krassas et al., 2010); the 
hypothesis that severe and prolonged thyroid deficiency occurring early in life can result in 
www.intechopen.com
 
Hypothyroidism, Oxidative Stress and Reproduction 
 
121 
abnormal testicular biopsies is based on histological and endocrine evaluation of 6 adult 
hypothyroid men (De la Balze et al., 1962). Similarly, in a group of 8 hypothyroid males, 
various degrees of testicular atrophy were shown (Wortsman et al., 1987). Another group of 
10 hypothyroid patients treated with T4 (with a discontinuation or decrease of therapy for at 
least a spermatogenetic cycle) presented a decrease in semen volume, progressive forward 
motility and cumulative percentage of mobile spermatozoa forms, but without significant 
changes in these parameters during the phase of reinduced hypothyroidism; it was 
concluded therefore that short-term postpubertal hypothyroidism does not cause severe 
seminal alterations (Corrales Hernàndez et al., 1990). 
Another prospective, controlled study evaluated semen analysis, biochemical parameters 
(fructose and acid phosphatase), teratozoospermia index and acridine orange test, in 25 
hypothyroid men, before and after 6-9 months T4 treatment (Krassas et al., 2008) in 
comparison with 15 normal fertile men. The authors concluded that hypothyroidism had an 
adverse effect on spermatogenesis, with sperm morphology as the only parameter that was 
significantly affected. These data, therefore, need to be reevaluated, considering the 
variations in parameters of fertile men which have been introduced by the new version of 
the WHO manual for semen analysis (WHO, 2010) which are remarkably different from 
those previously adopted as normal range (WHO, 1999). 
Finally, even if the topic of autoimmune thyroid disease (AITD) is extensively studied in 
females (see the following paragraph), some data in males are reported. The prevalence of 
thyroid antibody positivity in a population of infertile men was found to be 7.5%; there was 
no difference in prevalence of abnormal thyroid function tests in normozoospermic vs 
pathozoospermic patients (11.1 vs 11.8%), but when correlating thyroid autoimmunity with 
semen parameters, the authors found a significantly higher presence of TPO-Abs in 
pathozoospermic and asthenozoospermic vs normozoospermic infertile men (6.7% and 7.2% 
respectively vs 1.6%) (Trummer et al., 2001). This datum was not confirmed in other studies 
(Krassas et al., 2010). The causal effect of thyroid autoimmunity is far to be understood; only 
one study showed the presence of TPO-Abs in men with serum sperm autoantibodies 
(Paschke et al., 1994). 
The hypothesis that OS, which is well known to interfere with male fertility (Iwasaki & 
Gagnon, 1992; Aitken & Krausz, 2001; Agarwal & Saleh, 2002), can be related to thyroid 
disfunction induced us to perform a case-control study, evaluating TAC and seminal 
parameters in an unselected group of infertile man and controls (Mancini et al., 2009) and 
correlating these values with systemic hormones. TAC was measured using the system 
H2O2-metmyoglobin as source of radicals. They interact with the chromogenous 
compound 2,2I,-azinobis (3-ethylbenzothiazoline-6-sulphonate) (ABTS) generating its 
radical cationic form (ABTS+) which can be spectroscopically and kinetically detected 
(Rice-Evans & Miller, 1994;  Meucci et al., 2003). This colorimetric assay was compared 
with the enhanced chemiluminescence one, which is the most commonly used method for 
measuring TAC in seminal plasma (Said et al., 2003). The colorimetric assay was found to 
be a reliable and accurate method, simpler and cheaper than the chemiluminescence one. 
Antioxidants induce a “lag time” in accumulation and appearance of ABTS+ which is 
proportional to the antioxidant concentration itself, so that TAC can be expressed as Lag 
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phase. The possible release of intracellular antioxidants from broken cells was 
preliminarily excluded by measuring the enzyme LDH in seminal plasma specimens 
(Mancini et al., 1994). 
The correlation analysis between hormones and seminal parameters showed an inverse 
correlation between PRL and sperm motility, and a direct correlation of TAC with PRL and 
FT4, but not with gonadotropins or gonadal steroids. Our data suggest that systemic 
hormones may play a role in regulating seminal antioxidant capacity. This is interesting also 
because some hormones, such as thyroid and pituitary ones, are not usually tested in the 
first level evaluation of male patients with fertility problems. 
4. Hypothyroidism and female infertility 
Hypothyroidism is frequently associated with infertility, due to different reasons: altered 
peripheral estrogen metabolism, alterations in GnRH secretion causing abnormal pulsatile 
LH release, hyperprolactinemia and defects in hemostasis (Krassas, 2000).  
Similarly to what observed in males, plasma SHBG is decreased, with lowering of total T 
and estradiol, but their ubound fractions are increased. The metabolism is profoundly 
affected, with decrease of metabolic clearance rate of androstendione and estrone and 
increase in peripheral aromatization (Redmond, 2004; Longcope et al., 1990). The 5┙/┚ ratio 
of androgen metabolism is decreased and there is an augmented excretion of 2-oxygenated 
estrogens (Gallagher, 1966).  The alterations in steroid metabolism are corrected by 
replacement therapy (Gordon & Southren, 1977). As in male, gonadotropin levels are 
usually normal (Larsen, 1998), but with blunted or delayed response to GnRH (Marino et al., 
2006; Valenti et al., 1984). Hyperprolactinemia can be induced by augmented TRH secretion, 
also causing galactorrhea in some patients, reversible with thyroid therapy  (Honbo et al., 
1978). Finally, decreased levels of clotting factors VII, VIII, IX and XI have been shown and 
can contribute to polymenorrhea and menorrhagia (Ansell, 1996).  
Many studies have been performed also in subclinical hypothyroidism (SCH); the 
prevalence of SCH in infertile women was 11% in one study (Bohnet et al., 1981), but not  
considered as an infertility factors by others (Bals-Pratsch et al., 1997). A positive correlation 
was found in early follicular phase between basal TSH, LH and T; moreover women with 
elevated TSH response to TRH had lower pregnancy rate than women with normal TSH 
response (Gerhard et al., 1991). In a controlled prospective study of 438 women with 
infertility of various origin, the median TSH levels were significantly higher than controls 
(Poppe et al., 2002). Moreover more frequent miscarriages were observed in women with 
higher basal TSH levels, irrespective of the presence of AITD (Raber et al., 2003). 
We want to focuse our attention on luteal deficiency, on one side, and AITD, the most 
prevalent associated etiology in patients of reproductive age, on the other one.   
Progesterone secreted by the corpus luteum plays an important role in the maintenance of 
early pregnancy. Immediately after implantation, under the influence of human chorionic 
gonadotropin (hCG) secreted by the trophoblast, the corpus luteum receives a signal to 
continue to producing 17-┙-progesterone along with estradiol, estrone, and relaxin 
(Szlachter et al., 1980; Bigazzi et al., 1981). The corpus luteum maintains its capacity to 
synthesize progesterone almost throughout the pregnancy, but at approximately 7 weeks 
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gestation, its functional ability decreases markedly at the start of the luteoplacental 
transition. The removal of the corpus luteum before the eighth week of gestation results in 
abortion, whereas after the ninth week it does not (Csapo et al., 1973). Abnormalities of the 
luteal phase have been reported to occur in up to 35% of women with recurrent pregnancy 
losses (Insler, 1992). There are several causes for luteal phase deficiency, including stress, 
exercise, weight loss, hyperprolactinemia, and menstrual cycles at the onset of puberty or 
perimenopause. 
Luteal phase deficiency (LPD) presents without any significant change in menstrual cycle 
lenght, despite prolonged follicular phases and shortened progesterone-deficient luteal 
phases (De Souza et al., 1998). Clinically, LPD is associated with abnormal corpus luteal 
function, which includes the mentionated short luteal phases and inadequate progesterone 
production, and also inappropriate endometrial stimulation and maturation (Ginsburg, 
1992). These luteal phase alterations cause asynchronous follicular growth, compromised 
oocyte maturation, and differentiated (out of phase) function of the endometrium, which is 
associated with low rates of cycle fecundity and high rates of embryonic loss, i.e. infertility 
and spontaneous abortion (Ginsburg, 1992). 
As above stated, hypoactive thyroid hormone is associated with infertility, even if severe 
forms of hypothyroidism rarely complicate pregnancy because they are associated with 
anovulation. However, in mild hypothyroidism, pregnancies can occur and are associated 
with higher rates of pregnancy loss and maternal complications (Davis et al., 1988; Stray-
Pedersen & Stray-Pedersen, 1984). Even if an association exists between low thyroid 
function and pregnancy loss, a direct evidence for a causal role is missing  (Clifford et al., 
1994). One hypothesis for this correlation is that luteal phase defect has been linked to 
thyroid hypofunction. In consideration that production of progesterone is a pivotal element 
of a successful pregnancy, it is possible that pregnancy loss could be related to a deficient 
corpus luteum action ( Daya et al., 1988). 
An important study was published by Negro et al (2006) showing, in a large cohort of 
women, that patients with positive thyroid autoantibodies (TPO-ab), even if euthyroid at the 
early stages of pregnancy, would benefit from L-thyroxine administration to improve 
outcome of pregnancy, and namely the rate of spontaneous miscarriage and premature 
delivery. Ab-positive women  were significantly older than control population (suggesting 
that AITD could delay conception due to its relation with infertility) but exhibit a mean 
serum TSH, although normal, significantly higher than controls; women were randomly 
assigned to two groups, one without treatment, and the other with L-thyroxine treatment. In 
group without therapy, serum TSH progressively increased during gestation, in the 
meantime serum free T4 (FT4) decreased by 30%, suggesting reduced functional thyroid 
reserve due to AITD. On the contrary, in treated group, the miscarriage rate was reduced by 
75% and frequency of premature delivery by 69%.   Similar results were reported by other 
authors showing that age, TPO positivity and high TSH levels were independently 
associated with the risk of miscarriage in multivariate analysis (Sieiro Netto et al., 2004). An 
association between miscarriage and AITD had been previously described (Stagnaro-Green 
et al., 1990; Glinoer et al., 1991) and support in other population studies, confirming this 
association also in the case of apparent normal thyroid function (Poppe & Glinoer, 2003). A 
recent review separately considered association of AITD and miscarriage, AITD and 
recurrent miscarriage and finally AITD and early pregnancy loss after in vitro fertilization 
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(Stagnaro-Green & Glinoer, 2004). Finally another confirmation came from a meta-analysis 
of all case-controlled and longitudinal studies, with an increased risk by 3-fold. Poppe et al. 
performed a prospective cohort study in women undergoing the first Assisted Reproduction 
Technology (ART) cycle, excluding over thyroid dysfunction. The prevalence of antiTPO 
was 14%, without differences in TSH,  FT4 and age; in this positive group, pregnancy rate 
was 53% vs 43%, with an odds ratio of 0.67, but in pregnant  group the miscarriage rate was 
53% and 23% respectively, with and odds ratio of 3.77 (Poppe et al., 2003). Autoimmune 
thyroiditis are clearly associated with clinically relevant events occurring before, during and 
after pregnancy (Muller & Berghout, 2003). The hypothesis to explain this strong association 
were, of course, based on the concept of a generalized autoimmune disorders or a subtle 
thyroid hormone deficiency. 
In this sense, a light is brought by studies performed with the administration of L-thyroxine. 
Vaquero et al (2000)  included patients with Ab positivity and two previous first-trimester 
miscarriage, achieving a greater pregnancy outcome than untreated patients (81% vs 55%). 
Negro reported a reduction of miscarriage rate after L-thyroxine treatment in Ab positive 
infertile women who underwent in vitro fertilization (Negro et al., 2006). Finally, Abalovich 
et al. (2002) underlined the importance of adequate hormone treatment, comparing patients 
with hypothyroidism already known before pregnancy (adequate treatment) and patients 
with uncompletely adjusted replacement therapy: the pregnancy ended with abortion  in 
60% and 71% of cases, respectively.     
In conclusion we believe it is prudent to screen for thyroid disease and normalize thyroid 
functions, when these are found abnormal, prior to conception or to return to a “normal” 
menstrual cycle, moreover Ab+ women should be carefully evaluated before pregnancy for 
sublinical hypothyroidism.  
We report here some personal data on subclinical hypothyroidism, in couples users of  
Billings Ovulation Method (BOM); it is based on vulvar observation of the “Mucus 
Symptom”, whose pattern is an accurate and precise marker of the ovarian function (Bllings, 
1972), validated by laboratory research and field trials (Billings, 1991; Brown et al., 1987).  
BOM can be useful in studying subtle abnormalities in thyroid-gonadotropin interaction; the 
simple identification of the mucus peak and the evaluation of luteal phase length allow to 
detect a precise timing to perform hormonal assays. Therefore, we used BOM to evaluated 
the prevalence of subclinical hypothyroidism in women, users of the method for achieving 
or spacing pregnancy, and whose cycle abnormalities were not referred to cervical 
pathology. Preliminary data, still unpublished, but presented at the World Congress on 
Fertility & Sterility (Giacchi et al., 2007) were collected in 42 couples consulting our Center: 
22 exhibited an history of infertility (1-4 ys), with a range age of women: 26-42 ys.  Criteria 
of exclusion were male infertility and cervical pathology. Evaluation of progesterone levels 
was performed on the 6th-7th day after the “peak of mucus symptom”, or on the 6th-7th day 
before the expected menses, when no peak occurred. We evaluated basal plasma levels of 
FT3, FT4, TSH, PRL and performed a TRH test (200 ug iv, with TSH evaluation at 0, 30, 60 
min) when TSH was normal or high normal. The presence of anti-TPO and anti-
thyroglobulin autoantibodies was also evaluated. Progesterone (P), FT3 and FT4 were 
assayed by RIA; TSH was assayed by IRMA method. Coefficients of variation: intra-assay 
CV 2.6% for P, 3.8% for FT3, 4.1% for FT4, 4.5% for TSH; inter-assay CV 3.9% for P, 3.9% for 
FT3, 4.9% for FT4, 3.4% for TSH.  Normal ranges: Progesterone: 7-30 ng/ml; FT3: 2.3-4.2 
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pg/ml; FT4 8.5-15.5 pg/ml; TSH 0.35-2.80 µUI/ml. TRH (Relefact 200 µg) was fournished by 
Hoechst, Italy. Subclinical hypothyroidism was defined as TSH peak response > 15 µg/ml, 
according to previous studies and comparison with age-matched controls (Giacchi et al., 
2001). Women were classified in three groups according to the BOM mucus symptom 
different patterns: Anovulatory pattern of the mucus symptom (n=2),  post-peak phases 
shortened and/or affected by spotting (n=22), normal lenght of luteal phase, but P in the 
lower  range of postovulatory values (n=18); among these  two presented hypermenorrhea. 
Mean ± levels of the studied hormones are reported in table 1. Normal PRL levels were 
present in this group of patients. The prevalence of subclinical hypothyroidism, as above 
defined, in this group was 80%; prevalence of thyroid autoantibodies: 10%. After L-thyroxine 
treatment, we observed a clear and significant increase in progesterone levels (evaluated 6-7 
day after the “peak” of the “mucus symptom”) and the resumption of ovulation in the two 
women with anovulatory cycles (Fig. 1), strongly supporting a pathogenetic role of 
hypothyroidism in anovulation or luteal failure. 
women 
number
P (ng/ml) FT3 (pg/ml) FT4 (pg/ml)
basal TSH 
levels  
µU/ml
TSH peak  
μU/ml PRL (ng/ml)
2 0,3 + 0,2 3,6  + 1,5 9,0 + 0,5 3,4 + 0,8 24,5 + 1,5 19,5 + 1,0
< 11 g 22 10,7 + 1,1 4,0 + 1,0 10,1 + 0,8 2,7 + 0,2 21,2 + 1,5 16,1  + 1,6
> 11 g 18 9,1  + 0,8 3,8  + 1.0 9,1 + 0,8 3,0 + 0,2 22,5 + 1,3 17,5 + 1,2
No peak 
anovulatory 
cycles
post 
peak 
phase 
lenght
 
Table 1. Mean ± SEM hormone levels in patients consulting our Center for infertility and 
monitored by Billings’ Ovulation Method. 
An hypothesis linking thyroid dysfunction and luteal deficiency is that concerning OS. 
Oxidative stress is associated with decreased female fertility in animals and in vitro models, 
but some observations in humans also reinforces this concept. Exposures associated with OS 
(extremes of body weight, alcohol, tobacco and caffeine intake) may induce pregnancy 
complications (e.g. preeclampsia) ; while intake of antioxidants nutrients, included use of 
multivitamins, have a beneficial role in female fertility (Ruder et al., 2009). More recently, it 
has been hypothesized that the exposure to environmental pollutants in fetal life may alter 
DNA methylation, causing altered gene expression in adult life (Li et al., 1997; Anway et al., 
2005); therefore this widespread condition should be added to the factors favouring OS.  A 
role of reduced antioxidant defence has also been hyothesized in polycystic ovary, 
unexplained infertility and outcome of in vitro fertilization (Ruder et al., 2008). 
When specifically considering luteal function, it has been shown than the corpus luteum has 
a high concentrations of antioxidants, especially ┚-carotene, to which is related the bright 
yellow color (Rodgers et al., 1995); other carotenoids and vitamins C and E are also present 
and may contribute to ROS scavenging (Aten et al., 1992;  Matzuk et al., 1998; Behrman et 
al., 2001. Moreover ROS are produced during luteal regression (Behrman et al., 2001), in part 
through cytochrome P450 enzymes involved in the first step of steroidogenesis (Rodgers et 
al., 1995).  
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Fig. 1. Post-peak (according to BOM) Progesterone  levels (ng/ml) before and after 
replacement l-T4 treatment . 
However, the role of ROS in ovary is particularly complex.  On one side, they play a 
physiological role: regulated ROS generation by the pre-ovulatory follicle is an important 
promoter of ovulatory sequence; in particular, the resumption of meiosis I (MI) induced by 
hormonal factor after puberty, is induced by ROS and inhibited by antioxidants (Takami et 
al., 1999; Kodman & Behrman, 2001). Another beneficial effects could be related to a ROS 
involvement in intracellular signalling between hypoxia and angiogenig response (Basini et 
al.,2004). Surprisingly, antioxidants are, on the contrary, beneficial for MII, which arises in 
response to periovulatory LH peak (Behrman et al., 2001). Follicular ROS initiate apoptosis 
whereas follicular glutathione (GSH), in addition to FSH, protect against apoptosis in 
cultured preovulatory rat follicles (Tsai-Turton & Luderer, 2006). Moreover,  cyclical ROS 
production may contribute to oophoritis associated with autoimmune premature ovarian 
failure (Behrman et al., 2001).  It has been suggested that ROS under moderate 
concentrations play a role in signal transduction processes involved in growth and 
protection from apoptosis (Basini  et al., 2004). In rat thecal-intestitial cells, which regulate 
steroidogesis and follicle growth in secondary follicle, ROS induced a biphasic effect on 
proliferation (positive at lower and negative at higher concentrations). Therefore controlled 
ROS levels may be needed to maintain DNA synthesis, cell proliferation and growth of 
ovarian mesenchyme in such animal model (Duleba et al., 2004). Finally, epidemiologic data 
suggest a positive role of dietary antioxidants (Ruder et al., 2008): preconceptional 
multivitamin supplementation may enhance fertility, perhaps increasing menstrual cycle 
regularity (Czeizel et al., 1994;  Dudas et al., 1995) or via prevention of ovulatory disorders 
(Chavarro et al., 2007). Despite all these evidences, it must be reminded the difference by in 
vitro models and in vivo conditions and the need of more data of antioxidants levels in 
hypothyroidism, which could be useful for therapeutic purposes. 
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5. Conclusions 
Taken together, all the reported data confirm the role of thyroid hormones in human 
fertility; also subclinical hypothyroidism should be considered in the evaluation of an 
infertile couple, even if it is not routinely evaluated in the first level approach to this 
problem. Oxidative stress could be a phenomenon  liking hypothyroidism, also in 
subclinical form, with altered sperm motility, in males, and luteal phase deficiency in 
females, even if more experimental data are needed to give statistical evidence to this 
fascinating hypothesis. 
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